Advanced research progress and clinical hotspots of bipolar disorder in the past decade
10.3760/cma.j.cn113661-20241008-00322
- VernacularTitle:双相障碍近10年临床热点与研究进展
- Author:
Yiru FANG
1
;
Zuowei WANG
;
Jun CHEN
Author Information
1. 上海交通大学医学院附属瑞金医院情感障碍中心精神心理科，上海200025
- Publication Type:Journal Article
- Keywords:
Bipolar disorder;
Biological markers;
Heterogeneity;
Precision medicine;
Digital healthcare
- From:
Chinese Journal of Psychiatry
2025;58(2):87-93
- CountryChina
- Language:Chinese
-
Abstract:
Bipolar disorder (BD) is a heterogeneous group of diseases caused by multiple factors such as biology, psychology, and society. So far, there is a lack of specific biological markers for recognizing and diagnosing BD, and unmet clinical needs for diagnosis and treatment are widespread. This article summarizes changes in the diagnosis name and the progress of research in disease classification, epidemiology, etiology and pathogenesis, clinical diagnosis, evaluation, and treatment of BD in the past decade in China and the world. It also discusses hot topics such as precision medicine, diagnostic biomarkers, and digital healthcare for BD, and proposes thoughts on future clinical practice and scientific research in BD.
